Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves.
Bernhard WernlyAnn-Katrin ZappeAxel UnbehaunJan-Malte SinningChristian JungWon-Keun KimStephan FichtlschererMichael LichtenauerUta C HoppeBrunilda AlushiFrederik BeckhoffCharlotte WewetzerMarcus FranzDaniel KretzschmarEliano NavareseUlf LandmesserVolkmar FalkAlexander LautenPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2018)
In VinV-TAVR for SBV-failure is a safe procedure resulting in hemodynamic improvement in the majority of patients. Residual stenosis is a common finding which can be observed in 1/4 of patients undergoing VinV-TAVR. However, this condition is not associated with increased 1-year-mortality.
Keyphrases
- aortic valve
- transcatheter aortic valve replacement
- aortic stenosis
- aortic valve replacement
- transcatheter aortic valve implantation
- ejection fraction
- patients undergoing
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- left ventricular
- minimally invasive
- cardiovascular events
- peritoneal dialysis
- type diabetes
- coronary artery disease
- patient reported outcomes
- coronary artery
- risk factors
- pulmonary artery